NCT01355471 - Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea | Biotech Hunter

Enrollment

293

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

January 31, 2012

Conditions

Rosacea

Interventions

DRUG

CD07805/47 Gel

applied topically once daily

DRUG

Placebo

applied topically once daily

Trial Locations (15)

10155

Skin Specialty Dermatology, New York

29607

Palmetto Clinical Trial Services, LLC, Greenville

30263

MedaPhase, Inc., Newnan

33140

Baumann Cosmetic and Research Institute, Miami Beach

40202

Dermatology Specialists Research, Louisville

44118

Haber Dermatology & Cosmetic Surgery, South Euclid

48088

Grekin Skin Institute, Warren

63117

Central Dermatology PC, St Louis

71913

Burke Pharmaceutical Research, Hot Springs

77845

J&S Studies Inc., College Station

97210

Oregon Dermatology and Research Center, Portland

99201

Premier Clinical Research, Spokane

T25 3B3

Kirk Barber Research Inc., Calgary

A1A 5E8

Nexus Clinical Research, St. John's

A1C2H5

Newlab Clinical Research Inc., St. John's